JUN and hepatocellular carcinoma: Because the enrichment of c-Jun and Fos activity was detected in the hepatoblast subtype of HCC arising from bipotential HPCs, this indicated that the AP-1 complex was the major driving force in tumorigenesis of the hepatoblast subtype [3].